AURA Biotechnologies provides integrated biosimilar support services including cell line generation, product characterization, lot release testing, bioassays, safety studies, and clinical services. They offer a range of products and services to support biosimilar development including ELISA kits for pharmacokinetic and immunogenicity testing, recombinant proteins, antibodies, and microbiology testing services. Their goal is to simplify biosimilar research through high quality products and customized services that meet regulatory guidelines.